Overview

Local Non-salvage Radiotherapy for Synchronous Oligometastatic Non-small-cell Lung Cancer.

Status:
Recruiting
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
Aggressive therapy may improve survival in synchronous oligometastatic NSCLC and the goal of this clinical trial is to assess the efficacy and safety of local definitive radiotherapy in this subset of patients.
Phase:
Phase 2
Details
Lead Sponsor:
Southern Medical University, China